Drug Receptors (Drug Receptor)

Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified.
Also Known As:
Drug Receptor; Receptors, Drug; Receptor, Drug
Networked: 41 relevant articles (5 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Ingelman-Sundberg, M: 2 articles (01/2008 - 09/2001)
2. Wang, Wei: 1 article (01/2014)
3. Gonzalez-Malerva, Laura: 1 article (01/2014)
4. LaBaer, Joshua: 1 article (01/2014)
5. Yu, Xiaobo: 1 article (01/2014)
6. Bosch-Morell, Francisco: 1 article (01/2014)
7. Mérida, Salvador: 1 article (01/2014)
8. Navea, Amparo: 1 article (01/2014)
9. Muriach, María: 1 article (01/2014)
10. Yin, Linliang: 1 article (01/2014)

Related Diseases

1. Drug Toxicity (Drug Safety)
03/01/2004 - "Ina similar manner, polymorphisms in the genes encoding drug metabolizing enzymes, drug transporters, and drug receptors can influence a neonate's risk of an adverse drug reaction or can alter the efficacy of drug treatment. "
01/01/2008 - "Pharmacogenetics encompasses genetic variation with importance for drug response and adverse drug reactions with emphasis on drug transporters, drug metabolizing enzymes, and drug receptors. "
11/11/2000 - "Polymorphisms in the genes that code for drug-metabolising enzymes, drug transporters, drug receptors, and ion channels can affect an individual's risk of having an adverse drug reaction, or can alter the efficacy of drug treatment in that individual. "
12/01/1998 - "Major research challenges include the following: (1) the genetic variation of drug targets (receptors, enzymes, etc.), drug transporters (multispecific organic anion transporter, P-glycoprotein, alpha-1-acid glycoprotein, etc.), and drug-metabolizing enzymes (cytochrome P450s and other enzymes); (2) the structure and function of all genetic variants of drug receptors, transporters, and metabolizing enzymes; (3) the induction, repression, and inhibition of all components involved in drug disposition; (4) the development of noninvasive in vivo methods to determine the physiological significance of various components in the handling of specific therapeutic agents in humans; (5) the mechanism of idiosyncratic adverse drug reactions; and (6) the pharmacokinetic and pharmacodynamic relationships to explain the individual differences in therapeutic efficacy and drug safety. "
2. Uveitis
3. Urticaria (Hives)
4. Food Hypersensitivity (Food Allergy)
5. Angioedema

Related Drugs and Biologics

1. Enzymes
2. daclizumab (dacliximab)
3. Multidrug Resistance-Associated Proteins
4. P-Glycoprotein
5. Terfenadine (Seldane)
6. Pirenzepine
7. Orosomucoid (Seromucoid)
8. Ion Channels (Ion Channel)
9. Cytochromes
10. Neurotransmitter Agents (Neurotransmitter)

Related Therapies and Procedures

1. Subcutaneous Injections
2. Drug Therapy (Chemotherapy)